Saturday, March 31, 2007

Cancer vaccine stocks

Cancer vaccine stocks soar on Dendreon panel vote (Reuters)

Metastasized breast cancer cells are seen in the liver in an undated handout image from the National Cancer Institute. Shares of cancer vaccine makers soared on Friday after an advisory panel to the U.S. Food and Drug Administration recommended approval of a product made by Dendreon Corp. The surprise ruling paves the way for approval of the first ever cancer vaccine and provides a vote of confidence in a field that has been dogged by failure and investor skepticism. (Handout/Reuters)Reuters - Shares of cancer vaccine makers soared on Friday after an advisory panel to the U.S. Food and Drug Administration recommended approval of a product made by Dendreon Corp.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)